Trademarkia Logo

Canada

C$
Trademark Search in Canada
VISCOFAN FIBERCOLL-FLEX

View On IC.GC.CA

VISCOFAN FIBERCOLL-FLEX
ADVERTISED

on 23 Apr 2025

Last Applicant/ Owned by

VISCOFAN, S.A.

C/ Berroa nº 15 4ª pl. Polígono Industrial BerroaE-31192 TAJONAR (NAVARRA)

ES

Serial Number

2216864 filed on 28th Jul 2022

Correspondent Address

MARIE LUSSIER

(FOGLER, RUBINOFF LLP)Scotia Plaza, 40 King Street West, Suite 2400, P.O. Box 215Toronto

ONTARIO

CA

M5H3Y2

VISCOFAN FIBERCOLL-FLEX

Trademark usage description

biological materials and preparations for 3d printers, namely, bioinks, bioprinting kits, biological printed tissues for use in scientific and medical Read More

Classification Information

Class [001]
Biological materials and preparations for 3D printers, namely, bioinks, bioprinting kits, biological printed tissues for use in scientific and medical research, hydrogels for cell culture not for medical or veterinary purposes; hydrogels for cell growth not for medical or veterinary use; cell culture media for use in scientific and medical research; nutritional agents for processing living cells, namely, cell culture media and reservoirs for growth factors for use in scientific and medical research; culture media for microbiology; cell culture reagents for use in scientific and medical research; synthetic peptide substrates for use in analyzing and detecting toxins for laboratory or research use; stem cells for use in scientific and medical research; stem cells and biological tissue specimens in hydrogels for use in scientific and medical research; biologically compatible polymers, specifically hydrogels used to produce polymer networks used in the manufacture of engineered living tissues for medical, scientific and non-scientific purposes; cell culture media for use in the biotechnological industry; cell culture media for use in non-medical research laboratories; engineered living tissues and tissue arrays, namely, human and animal organs, connective tissue, epithelial tissue, muscular tissue and nervous tissue, and tissue arrays, for use in scientific and medical research; biologically compatible materials, specifically, hydrogels used to create polymeric networks used in the manufacture of living tissues; proteins in the form of raw materials for scientific and medical research.

Classification kind code

11

Class [002]
Inks of biological origin for printers; inks of biological origin for 3D printers.

Classification kind code

11

Class [005]
Hydrogels for medical, veterinary and pharmaceutical purposes for cellular biology applications, namely, for use in bioprinting, cell tissue culture, regenerative therapies and medical technologies; hydrogels for cell growth, cell growth and transplantation, assays based on cells, cancer cell research, regenerative medicine, stem cell growth and drug delivery; hydrogels for cell culture for medical, veterinary and pharmaceutical purposes, namely for use in bioprinting, cell tissue culture, regenerative therapies and medical technologies; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes, namely for use in bioprinting, cell tissue culture, regenerative therapies and medical technologies; cell culture media for medical use; nutritional agents for processing living cells, namely, cell culture media and reservoirs for medical, veterinary and pharmaceutical use; synthetic peptide substrates for the treatment of degenerated hard and soft tissues; stem cells for medical, veterinary and pharmaceutical use; stem cells and biological tissue specimens in hydrogels for medical, veterinary and pharmaceutical use; pharmaceutical preparations based on cellulose nanofibers for use in 3D bio-printing of tissues and organs; stem cells for medical use; allogeneic human tissue; implantation of living tissue with controlled tissue regeneration; implants containing living tissue; implantable living tissue materials for use in guided tissue regeneration; skin grafts; surgical implants formed by living tissue; surgical implants of living tissues derived from stem cells; transdermal patches for the creation of skin for prostheses and skin grafts; living tissue for transplants; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular, and nervous tissues and organs, for medical purposes; biological molecules to assist in tissue engineering; hemostatic gel matrix preparations for wound treatment; natural biomaterials for the growth of bones, blood and tissues for medical purposes; pharmaceutical preparations for the treatment of diseases of bones, cartilages, blood vessels, nerve cell degeneration, tendon and ligament degeneration, retinal degeneration, kidney degeneration, soft tissue degenerations, for diseases with abnormal cell growth; natural biomaterial for bone filling; natural biomaterial for cartilage filling; biological tissue cultures for medical purposes; arterial, skin, and vascular grafts derived from living biological tissue; bone and skin biological tissues impregnated with oxygen lines for tissue constructs applicable for increasing the cell survival in tissue intended for subsequent implants; implantable stents containing living tissue to maintain the structure of the tissue; natural biomaterial for bone and tissue growth for medical purposes.

Classification kind code

11

Mark Details

Serial Number

2216864

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 7th Aug 2024		Agent Changed
Submitted for opposition 22
on 7th Feb 2024		Search Recorded
Submitted for opposition 20
on 7th Feb 2024		Examiner's First Report
Submitted for opposition 223
on 7th Feb 2024		Total Provisional Refusal
Submitted for opposition 256
on 21st Aug 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 20th Oct 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Oct 2022		Created
Submitted for opposition 31
on 19th Oct 2022		Formalized
Submitted for opposition 30
on 28th Jul 2022		Filed
Submitted for opposition 228
on 28th Jul 2022		International Registration